Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Using hyaluronidase medication to correct adverse events post soft tissue augmentation

Using hyaluronidase medication to correct adverse events post soft tissue augmentation As hyaluronic acid (HA) has become one of the most common facial aesthetic augmentation filler agents, the need to effectively deal with procedure-related complications is much greater. Adverse events such as overcorrection and asymmetries owing to product misplacement through poor injection technique can undermine positive treatment outcomes because, although they are classed as temporary, HA-based dermal fillers can last up to 12 months or longer. Hyaluronidase treatment fortunately offers aesthetic practitioners a potential solution to multiple HA-filler based adverse effects. When used correctly, hyaluronidase is also an effective treatment for some serious adverse reactions to HA and can help to remove unwanted HA deposits. It has also been shown to be useful in managing rare granulomatous foreign-body reactions to HA and delayed onset nodules, once infection or inflammation have been treated or ruled out. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Aesthetic Nursing Mark Allen Group

Using hyaluronidase medication to correct adverse events post soft tissue augmentation

Journal of Aesthetic Nursing , Volume 3 (4): 5 – May 1, 2014

Loading next page...
 
/lp/mark-allen-group/using-hyaluronidase-medication-to-correct-adverse-events-post-soft-CQnUOur90E

References (20)

Publisher
Mark Allen Group
Copyright
Copyright © 2014 MA Healthcare Limited
ISSN
2050-3717
eISSN
2052-2878
DOI
10.12968/joan.2014.3.4.172
Publisher site
See Article on Publisher Site

Abstract

As hyaluronic acid (HA) has become one of the most common facial aesthetic augmentation filler agents, the need to effectively deal with procedure-related complications is much greater. Adverse events such as overcorrection and asymmetries owing to product misplacement through poor injection technique can undermine positive treatment outcomes because, although they are classed as temporary, HA-based dermal fillers can last up to 12 months or longer. Hyaluronidase treatment fortunately offers aesthetic practitioners a potential solution to multiple HA-filler based adverse effects. When used correctly, hyaluronidase is also an effective treatment for some serious adverse reactions to HA and can help to remove unwanted HA deposits. It has also been shown to be useful in managing rare granulomatous foreign-body reactions to HA and delayed onset nodules, once infection or inflammation have been treated or ruled out.

Journal

Journal of Aesthetic NursingMark Allen Group

Published: May 1, 2014

There are no references for this article.